header-medias

Presse release

GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year.

Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology,...

RELIEF, a strategic project for GlioCure, selected by EUREKA!

Angers, France - GlioCure SAS, a biotechnology company specialized in neuro-oncology,...

GlioCure receives the "Seal of Excellence" from the European Commission

GlioCure was awarded the "Seal of Excellence" under the H2020 Instrument PME phase 1 scheme for...

Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease

Three European companies to use Merck’s Advance Biotech Grant prizes to accelerate...

An eminent oncologist joins the GlioCure Scientific and Medical Advisory Board

Dr. Jean-Pierre BIZZARI, world renowned expert in oncology, is joining GlioCure's Scientific and...